Search Within

GME, Medicine

Formats
  1. Meeting Abstract (757)
  2. Journal Article (560)
  3. Review (144)
  4. Editorial (65)
  5. Research Letter (61)
  6. Correspondence (24)
  7. Guidelines (6)
  8. Miscellaneous (6)
  9. Book Section (5)
  10. Conference Paper (4)
Groups
  1. Graduate Medical Education (1632)
  2. Department of Medicine (1288)
  3. Hematology-Oncology Fellows (1085)
  4. Hematologic Malignancies, Division of (773)
  5. Solid Tumor Oncology Division (644)
  6. Weinberg Fellows (616)

More Groups

People
  1. Kylee Maclachlan (155)
  2. Gunjan Shah (154)
  3. Michael Scordo (146)
  4. Saad Usmani (135)
  5. Sergio Giralt (134)
  6. Alexander Lesokhin (120)

More People

Years
  1. 2025 (160)
  2. 2024 (426)
  3. 2023 (404)
  4. 2022 (323)
  5. 2021 (154)
  6. 2020 (73)

More Years

Publications
  1. Blood (310)
  2. Journal of Clinical Oncology (232)
  3. Clinical Lymphoma, Myeloma and Leukemia (46)
  4. Clinical Cancer Research (43)
  5. Annals of Oncology (37)
  6. Blood Advances (34)

More Publications

Publishers
  1. American Society of Hematology (349)
  2. American Society of Clinical Oncology (267)
  3. Elsevier Inc. (204)
  4. Nature Publishing Group (111)
  5. American Association for Cancer Research (101)
  6. Oxford University Press (70)

More Publishers

Results (1632)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical implications of the cancer genome atlas molecular classification system in esophagogastric cancer
    Journal Article

    Walch, H. S.; Borpatragohain, R.; Jee, J.; Chatila, W.; Fong, C.; Maron, S. B.; Ku, G. Y.; Ilson, D. H.; Janjigian, Y. Y.; Wu, A. J.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Diverse ERBB2/ERBB3 activating alterations and coalterations have implications for HER2/3-targeted therapies across solid tumors
    Journal Article

    Liu, D.; Jee, J.; Drilon, A.; Heilmann, A. M.; Allen, J. M.; Schrock, A. B.; Keller-Evans, R. B.; Li, B. T.
    Cancer Research Communications (2025)

    Fulltext@MSK | Save
  • Top advances of the year: Neoadjuvant immunotherapy in melanoma
    Editorial

    Chen, M. F.; Postow, M. A.
    Cancer (2025)

    Fulltext@MSK | Save
  • Disparities in receipt of palliative-intent treatment among disaggregated Hispanic populations with breast, lung, and prostate cancer in the United States
    Journal Article

    Garg, S. K.; Kohli, K.; Garg, I. K.; Garg, Y. K.; Nguyen, L. G.; Nguyen, I. S.; Feliciano, E. J. G.; Baez, Y. A.; Mahal, B. A.; Iyengar, P.; more...
    Cancer (2025)

    Fulltext@MSK | Save
  • A phase 1b/2 study evaluating the activity of tinengotinib in combination with androgen receptor pathway inhibitors (ARPIs) in patients with metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Abida, W.; Chen, Y.; McHugh, D. J.; Morris, M. J.; Wu, F.; Peng, P.; Hennessy, K.; Wang, H.; Fan, J.; Zaidi, S.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Outcomes with first-line ipilimumab and nivolumab for patients with metastatic renal cell carcinoma by number of doses
    Meeting Abstract

    Doshi, S. D.; Sanmiguel, A. L.; Knezevic, A.; Kotecha, R. R.; Shah, N. J.; Carlo, M.; Feldman, D. R.; Motzer, R. J.; Voss, M. H.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Local definitive therapy (LDT) utilization patterns and outcomes in chromophobe renal cell carcinoma (chRCC) with metachronous metastasis: A multi-institution study
    Meeting Abstract

    Dizman, N.; Doshi, S. D.; Knezevic, A.; Feinaj, A.; Sayegh, N.; Hobeika, C.; Alaghehbandan, R.; Rives, H.; Zengin, Z. B.; Braun, D. A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Investigation of ferroptosis and mTOR signaling in chromophobe renal cell carcinoma (ChRCC)
    Meeting Abstract

    Madsen, K. N.; Labaki, C.; Saad, E.; Alchoueiry, M.; Bi, K.; Hobeika, C.; Bakouny, Z.; Priolo, C.; Khabibullin, D.; Schindler, N. R.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Characterizing the immune effects of enfortumab vedotin (EV) on peripheral blood mononuclear cells (PBMCs) in metastatic urothelial cancer patients (mUC)
    Meeting Abstract

    Gupta, A.; Sevilla, C.; Pihlstrom, N. L.; Liang, S.; Regazzi, A. M.; McCoy, A. S.; Maher, C. A.; Wong, P.; Ahmed, F.; Funt, S. A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Clinical outcomes for radiographic node-positive prostate cancer following definitive radiotherapy
    Meeting Abstract

    Dodge, J.; Boe, L. A.; Boehm, K.; Guttmann, D.; Moore, Z.; Parikh, D.; Barsky, A.; Kollmeier, M.; McBride, S. M.; Brennan, V.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save